Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kalaris Therapeutics, Inc.

KLRS Clue Score19
United States Fiscal year ends December CIK 0001754068 Results filed 11 Aug 2026

What the insiders did Net buying

Nothing of that kind in this period.

What was left out

Form 4 filings counted 320
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 0
Sales at will 310
Transactions with no price 0
Shares from compensation/vesting 121,627,984
Sales filed before the plan box existed 217
History held since 31 Jul 2020